championsoncology.com - CSBR Balans kapitallashuviga qarzlar

Champions Oncology, Inc. (CSBR) korporativ emblemasi va logotipi

Champions Oncology onkologik tadqiqotlarning barqaror moliyalashtirilishi orqali barqaror R&D jarayonini ta'minlaydi. Umumiy majburiyatlarning kitob kapitalizatsiyasiga nisbati ushbu makro-barqarorlikni vizuallashtiradi, bunda 2.92 qiymati qarz yuklamasining joriy darajasini ko'rsatadi. Biotexnologiya gigantlarining aniqlik test platformalariga bo'lgan ortib borayotgan talabi preklinik bozorini kengaytirmoqda. Tirik o'smalarning noyob ekotizimi dori vositalarini klinik sinovlardan oldin samarali tasdiqlash imkonini beradi.

Champions Oncology Inc - CSBR Balans qiymatiga qarzlar (davr: 04.07.2022 - 29.10.2026)

championsoncology.com (CSBR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Narx grafigi Champions Oncology, Inc.|CSBR - Investitsiya uylarining umumiy prognozi
- emitentning bozor qiymati haqida ma'lumotlar:
Bozor kapitallashuvi CSBR|CSBR - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga balans qiymati Champions Oncology|CSBR - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati championsoncology.com|CSBR - Aktivlarning umumiy qiymati
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Champions Oncology|CSBR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Champions Oncology, Inc.|CSBR - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati CSBR|CSBR - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Champions Oncology|Tezkor likvidlik koeffitsiyenti championsoncology.com
Kompaniyaning barcha koʻrsatkichlari tahlili:Champions Oncology Corp (CSBR)
championsoncology.com tomonidan chiqariladigan mahsulotlar

Investorlar bozor tebranishlari sharoitida kapital barqarorligida fundamental tayanch nuqtasini izlamoqdalar. Champions Oncology (CSBR) uchun biomateriallarni tezkor yetkazib berishning operatsion samaradorligi juda muhimdir va barqaror moliyalashtirishni talab qiladi. Qarzning kapitalga nisbati tarixiy ko'rsatkichlari kompaniyaning o'z kapitaliga nisbatan jalb qilingan mablag'lar ulushini namoyish etadi. Ushbu koeffitsiyentning past qiymati moliyaviy mustaqillikni va bankrotlikdan himoyalanganlikni tasdiqlaydi. Bunday muvozanat uzoq muddatda aktivning ishonchliligini kafolatlaydi.

Champions Oncology raqobatchilari

Qarzning balans kapitallashuviga nisbati BeiGene Ltd ONC|HALO: Qarzning balans qiymatiga nisbati|Revolution Medicines, Inc. - Balans kapitallashuviga qarzlar|Ascentage Pharma Group International (AAPG) - Qarzning balans qiymatiga nisbati|CGON: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar UroGen Pharma Corp (URGN)|Qarzning balans kapitallashuviga nisbati Bicara Therapeutics Inc.|PSNL: Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati ERAS (Erasca)|DCTH (Delcath Systems Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar YMAB (YmAbs)|AURA - Qarzning balans qiymatiga nisbati|CADL: Qarzning balans qiymatiga nisbati|ARAY - Balans kapitallashuviga qarzlar|sellaslifesciences.com (SLS) - Qarzning balans kapitallashuviga nisbati|Actuate Therapeutics Inc. - Qarzning sof aktivlarga nisbati|CTOR (Citius Oncology, Inc) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar TuHURA HURA|Balans kapitallashuviga qarzlar TARA|Qarzning balans qiymatiga nisbati fatetherapeutics.com FATE|Balans kapitallashuviga qarzlar WHWK (Aadi Bioscience)|Qarzning sof aktivlarga nisbati TCRX|XBiotech USA - Balans kapitallashuviga qarzlar|CVM - Balans kapitallashuviga qarzlar|OS Therapies Incorporated (OSTX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati radiopharmtheranostics.com|Qarzning balans kapitallashuviga nisbati Artiva Biotherapeutics Inc.|Adlai Nortye Limited - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar VERU|Sof aktivlarga qarzlar Tempest Therapeutics Corp|Qarzning balans kapitallashuviga nisbati Xilio Therapeutics XLO|Renovaro Biosciences (RENB) - Balans qiymatiga qarzlar|MURA - Qarzning balans kapitallashuviga nisbati|KAPA (Kairos Pharma Ltd) - Qarzning balans qiymatiga nisbati|onkuretherapeutics.com (OKUR) - Qarzning balans kapitallashuviga nisbati|GDTC - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati CRIS|APLM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Tharimmune (THAR)|ADVB - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Genprex, Inc GNPX|CLDI: Qarzning balans qiymatiga nisbati|Sunshine Biopharma, Inc. - Balans kapitallashuviga qarzlar|Xenetic Biosciences (XBIO) - Qarzning balans qiymatiga nisbati|Salarius Pharmaceuticals, Inc. (SLRX) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Purple Biotech Ltd (PPBT)|Qarzning balans kapitallashuviga nisbati American Oncology Network Inc|Qarzning balans kapitallashuviga nisbati BGNE|Qarzning balans kapitallashuviga nisbati Checkpoint Therapeutics (CKPT)|ELEV - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar ICAD (iCAD)|Qarzning sof aktivlarga nisbati Ikena Oncology Inc.|NTBL: Qarzning balans qiymatiga nisbati|Balans qiymatiga qarzlar Viracta Therapeutics|MOR: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati nayabiosciences.com|Qarzning balans kapitallashuviga nisbati Ascentage Pharma